Medical organizational analysis of cancer morbidity, prevalence and mortality (Udmurt Republic data based)
Abstract
Introduction. Cases of Cancer have proved to be the leading causes of morbidity and mortality and determine the need for medical organizational analysis in order to improve public health system. Aim — to make a medical organizational analysis of cancer morbidity, prevalence and mortality in Udmurt Republic (UR). Materials and methods. The object of the research is the healthcare system of the UR (2002–2022). Data taken from from Rosstat (RF) and the Medical Information and Analytical Center of the Ministry of Health of the UR (2002–2022) were analyzed. The dynamics of cancer morbidity, prevalence and mortality (per 100 thousand population) in the UR and the RF were concidered. Vectors for improving of public health care for patients with cancer have been identified. Research methods: literature analysis, analytical, statistical, time series, comparative. Results and discussion. In 2002–2022, the dynamics of growth of cancer morbidity, prevalence and mortality and a shortage of oncologists in the Udmurt Republic were determined. The cancer morbidity increased from 260.5 to 486.6 per 100 thousand population (growth rate 186.8%, rate of increase 86.8%), more significantly among the urban compared to the rural population — positive growth of 60.5% and 49.5%, respectively; the cancer prevalence increased from 1296.5 to 2839.8 per 100 thousand population (growth rate 223.2%, rate of increase 123.2%); the proportion of patients with stage IV malignant neoplasms decreased in 2002–2012 and 2020–2022 to 21.5% and 23.8%, respectively, and increased in 2002–2020 to 25.8%; cancer mortality increased from 160.8 to 192.0 per 100 thousand population (growth rate 119,4%, rate of increase 19,4%), more significantly among the rural than among the urban population — the positive growth was 32.8% and 15.7%, respectively. The provision of oncologists in the Udmurt Republic in 2022 was 0.78 per 10 thousand population. Conclusions. The growth of cancer morbidity, prevalence and mortality and shortage of oncologists in the UR in 2012–2022 defined the need of improvement of oncological care by means of introduction of effective clinical organizational management models based on shift and telemedicine technology.
References
Bray F., Laversanne M., Weiderpass E., Soerjomataram I. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer. 2021;127(16):3029–3030. https://doi.org/10.1002/cncr.33587.
Ferlay J., Ervik M., Lam F., Laversanne M., Colombet M., Mery L., Piñeros M., Znaor A., Soerjomataram I., Bray F. Global Cancer Observatory: Cancer Today (version 1.1). Lyon, France: International Agency for Research on Cancer. 2024. Available at: https://gco.iarc.who.int/today (accessed 12.09.2024).
Chen S., Cao Z., Prettner K., Kuhn M., Yang J., Jiao L., Wang Z., Li W., Geldsetzer P., Bärnighausen T., Bloom D., Wang C. Estimates and projections of the global economic cost of 29 cancers in 204 countries and territories from 2020 to 2050. JAMA Oncol. 2023;9(4):465–472. https://doi.org/10.1001/jamaoncol.2022.7826.
Guida F., Kidman R., Ferlay J., Schüz J., Soerjomataram I., Kithaka B., Ginsburg O., Mailhot Vega R., Galukande M., Parham G., Vaccarella S., Canfell K., Ilbawi A., Anderson B., Bray F., Dos-Santos-Silva I., McCormack V. Global and regional estimates of orphans attributed to maternal cancer mortality in 2020. Nat Med. 2022;28(12):2563–2572. https://doi.org/10.1038/s41591-022-02109-2.
International Agency for Research on Cancer. Available at: https://www.cancer.gov/policies/linking (accessed 12.06.2024).
Bray F., Laversanne M., Sung H., Ferlay J., Siegel R., Soerjomataram I., Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2024;74(3):229–263. https://doi.org/10.3322/caac.21834.
Siegel R., Miller K., Wagle N., Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17–48. https://doi.org/10.3322/caac.21763.
Santucci C., Mignozzi S., Malvezzi M., Boffetta P., Collatuzzo G., Levi F., La Vecchia C., Negri E. European cancer mortality predictions for the year 2024 with focus on colorectal cancer. Ann Oncol. 2024;35(3):308–316. https://doi.org/10.1016/j.annonc.2023.12.003.
Шахзадова А.О., Старинский В.В., Лисичникова И.В. Состояние онкологической помощи населению России в 2022 году. Сибирский онкологический журнал. 2023;22(5):5–13. https://doi.org/10.21294/1814-4861-2023-22-5-5-13.
Состояние онкологической помощи населению России в 2022 год. Каприн А.Д., Старинский В.В., Шахзадова А.О., ред. М.: МНИОИ им. П.А. Герцена — филиал ФГБУ «НМИЦ радиологии» Минздрава России; 2022.
Голощапов-Аксенов Р.С., Рукодайный О.В., Колединский А.Г., Шабуров Р.И., Волков П.С., Тхакур А.С. Модель врача-специалиста на этапе первичной медико-санитарной помощи при сердечно-сосудистых заболеваниях. Комплексные проблемы сердечно-сосудистых заболеваний. 2022;11(4S):125–133. https://doi.org/10.17802/2306-1278-2022-11-4S-125-133.
Улумбекова Г.Э., Альвианская Н.В., Петрачков И.В. Организация и финансирование онкологической помощи в РФ в 2018–2024 гг. ОРГЗДРАВ: новости, мнения, обучение. Вестник ВШОУЗ. 2022;8(1):33–74. https://doi.org/10.33029/2411-8621-2022-8-1-33-74.
Распоряжение Правительства Удмуртской Республики от 21 июня 2019 г. № 725-р «Об утверждении региональной программы “Борьба с онкологическими заболеваниями в Удмуртской Республике на 2019–2024 годы”» (с изменениями от 25 сентября 2023 г.). Доступен по: https://docs.cntd.ru/document/561420199 (дата обращения 12.06.2024).
Голощапов-Аксенов Р.С., Багин С.А., Рукодайный О.В., Кича Д.И. Опыт применения вахтовой волонтерской технологии первичной специализированной медико-санитарной помощи сельскому населению при сердечно-сосудистых заболеваниях. Бюллетень НЦССХ им. А.Н. Бакулева РАМН. Сердечно-сосудистые заболевания. Тезисы докладов и сообщений. ХХХ Всероссийский съезд сердечно-сосудистых хирургов. г. Москва, 24–27 ноября 2024 г. 2024;25(6, Приложение):205.
